Malvika is a CEO of Rare Disease Watch, with expertise in commercial strategy, real-world evidence, competitive intelligence and emerging health technologies.

Her experience spans rare diseases, oncology, immunology and healthcare innovation, with a focus on evidence strategy, market intelligence, asset positioning and commercialisation. She has worked with R&D leaders, clinicians, KOLs and commercial teams to bridge the gap between scientific insights and real-world healthcare decisions.

Through Rare Disease Watch, Malvika is committed to advancing rare disease awareness and improving health literacy by making complex research and healthcare information more accessible, evidence-based and patient-centred.